Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 24 November 2009
Vol. 2, Issue 98, p. ra75
[DOI: 10.1126/scisignal.2000559]

RESEARCH ARTICLES

Editor's Summary

Restoring Hematopoietic Function
Hematopoietic stem cell (HSC) function decreases with age, a process that likely contributes to the weakened adaptive immune response characteristic of older individuals. Chen et al. found that HSCs from old mice showed increased activation of mammalian target of rapamycin (mTOR) signaling compared to those from young mice. Intriguingly, inhibition of mTOR with the drug rapamycin reversed aging-related declines in mouse HSC function and enhanced the ability of old mice to mount an effective immune response to infection with influenza virus. The authors thus propose that manipulation of mTOR signaling may lead to therapeutic approaches to restoring aging-related declines in HSC function.

Citation: C. Chen, Y. Liu, Y. Liu, P. Zheng, mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells. Sci. Signal. 2, ra75 (2009).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Rapamycin Extends Life and Health in C57BL/6 Mice.
Y. Zhang, A. Bokov, J. Gelfond, V. Soto, Y. Ikeno, G. Hubbard, V. Diaz, L. Sloane, K. Maslin, S. Treaster, et al. (2013)
J Gerontol A Biol Sci Med Sci
   Abstract »    Full Text »    PDF »
Sirtuins, Tissue Maintenance, and Tumorigenesis.
M. Mohrin and D. Chen (2013)
Genes & Cancer
   Abstract »    Full Text »    PDF »
Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate.
V. A. Rafalski, E. Mancini, and A. Brunet (2012)
J. Cell Sci. 125, 5597-5608
   Abstract »    Full Text »    PDF »
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling.
L. Rossi, V. Salvestrini, D. Ferrari, F. Di Virgilio, and R. M. Lemoli (2012)
Blood 120, 2365-2375
   Abstract »    Full Text »    PDF »
A Critical Role for Rictor in T Lymphopoiesis.
F. Tang, Q. Wu, T. Ikenoue, K.-L. Guan, Y. Liu, and P. Zheng (2012)
J. Immunol. 189, 1850-1857
   Abstract »    Full Text »    PDF »
Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival.
F. J. Ramos, S. C. Chen, M. G. Garelick, D.-F. Dai, C.-Y. Liao, K. H. Schreiber, V. L. MacKay, E. H. An, R. Strong, W. C. Ladiges, et al. (2012)
Science Translational Medicine 4, 144ra103
   Abstract »    Full Text »    PDF »
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity.
D. W. Lamming, L. Ye, P. Katajisto, M. D. Goncalves, M. Saitoh, D. M. Stevens, J. G. Davis, A. B. Salmon, A. Richardson, R. S. Ahima, et al. (2012)
Science 335, 1638-1643
   Abstract »    Full Text »    PDF »
Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing.
A. V. Ergen, N. C. Boles, and M. A. Goodell (2012)
Blood 119, 2500-2509
   Abstract »    Full Text »    PDF »
Empowering Adult Stem Cells for Myocardial Regeneration.
S. Mohsin, S. Siddiqi, B. Collins, and M. A. Sussman (2011)
Circ. Res. 109, 1415-1428
   Abstract »    Full Text »    PDF »
Cell cycle regulation in hematopoietic stem cells.
E. M. Pietras, M. R. Warr, and E. Passegue (2011)
J. Cell Biol. 195, 709-720
   Abstract »    Full Text »    PDF »
An emerging role for TOR signaling in mammalian tissue and stem cell physiology.
R. C. Russell, C. Fang, and K.-L. Guan (2011)
Development 138, 3343-3356
   Abstract »    Full Text »    PDF »
The Tuberous Sclerosis Complex-Mammalian Target of Rapamycin Pathway Maintains the Quiescence and Survival of Naive T Cells.
Q. Wu, Y. Liu, C. Chen, T. Ikenoue, Y. Qiao, C.-S. Li, W. Li, K.-L. Guan, Y. Liu, and P. Zheng (2011)
J. Immunol. 187, 1106-1112
   Abstract »    Full Text »    PDF »
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice.
R. A. Miller, D. E. Harrison, C. M. Astle, J. A. Baur, A. R. Boyd, R. de Cabo, E. Fernandez, K. Flurkey, M. A. Javors, J. F. Nelson, et al. (2011)
J Gerontol A Biol Sci Med Sci 66A, 191-201
   Abstract »    Full Text »    PDF »
Mammalian models of extended healthy lifespan.
C. Selman and D. J. Withers (2011)
Phil Trans R Soc B 366, 99-107
   Abstract »    Full Text »    PDF »
Targeting the CXCR4-CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1.
P. Fiorina, M. Jurewicz, A. Vergani, A. Petrelli, M. Carvello, F. D'Addio, J. G. Godwin, K. Law, E. Wu, Z. Tian, et al. (2011)
J. Immunol. 186, 121-131
   Abstract »    Full Text »    PDF »
2009: Signaling Breakthroughs of the Year.
E. M. Adler (2010)
Science Signaling 3, eg1
   Abstract »    Full Text »    PDF »
Science Signaling Podcast: 5 January 2010.
M. B. Yaffe and A. M. VanHook (2010)
Science Signaling 3, pc1
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882